Giovanni Marconi Selected Research

Giovanni Marconi Research Topics

13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 12/2016
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 01/2018
4	Neoplasms (Cancer) 12/2023 - 01/2018
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 01/2018
2	Leukemia 01/2023 - 01/2022
2	Philadelphia Chromosome 01/2022 - 01/2021
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 12/2023
1	Cytopenia 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Disseminated Intravascular Coagulation 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Inflammation (Inflammations) 11/2022
1	Bacterial Infections (Bacterial Infection) 06/2022
1	Infections 06/2022
1	Exanthema (Rash) 01/2022
1	Asthenia 01/2022
1	Erythema 01/2022
1	Aneuploidy (Aneuploid) 10/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 06/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2016
1	Residual Neoplasm 10/2015

4	Inotuzumab OzogamicinIBA 12/2023 - 11/2018
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 07/2020
2	venetoclaxIBA 01/2023 - 06/2022
2	ponatinibIBA 01/2022 - 01/2021
2	CohesinsIBA 01/2022 - 10/2021
1	Imatinib Mesylate (Gleevec)FDA Link 12/2023
1	magrolimabIBA 01/2023
1	sabatolimabIBA 01/2023
1	pembrolizumabIBA 01/2023
1	NivolumabIBA 01/2023
1	AlbuminsIBA 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Methylprednisolone FDA LinkGeneric 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	glasdegibIBA 01/2023
1	Semaphorins (Semaphorin)IBA 11/2022
1	AntigensIBA 10/2022
1	olaparibIBA 01/2022
1	rucaparibIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	talazoparibIBA 01/2022
1	SteroidsIBA 01/2022
1	veliparibIBA 01/2022
1	niraparibIBA 01/2022
1	ChromatinIBA 10/2021
1	nutlin 3IBA 04/2021
1	nelarabine (506U78)FDA Link 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2020
1	adavosertibIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Azacitidine (5 Azacytidine)FDA Link 12/2016

11	Therapeutics 01/2023 - 12/2016
3	Precision Medicine 10/2023 - 01/2022
3	Drug Therapy (Chemotherapy) 06/2022 - 10/2015
2	Hematopoietic Stem Cell Transplantation 12/2023 - 01/2021
2	Stem Cell Transplantation 01/2021 - 06/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2023
1	Biological Therapy 01/2023